Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder

Noa Lipstein, Nanda M. Verhoeven-Duif, Francesco E. Michelassi, Nathaniel Calloway, Peter M. Van Hasselt, Katarzyna Pienkowska, Gijs Van Haaften, Mieke M. Van Haelst, Ron Van Empelen, Inge Cuppen, Heleen C. Van Teeseling, Annemieke M.V. Evelein, Jacob A. Vorstman, Sven Thoms, Olaf Jahn, Karen J. Duran, Glen R. Monroe, Timothy A. Ryan, Holger Taschenberger, Jeremy S. Dittman & 4 others Jeong Seop Rhee, Gepke Visser, Judith J. Jans, Nils Brose

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Munc13 proteins are essential regulators of neurotransmitter release at nerve cell synapses. They mediate the priming step that renders synaptic vesicles fusion-competent, and their genetic elimination causes a complete block of synaptic transmission. Here we have described a patient displaying a disorder characterized by a dyskinetic movement disorder, developmental delay, and autism. Using whole-exome sequencing, we have shown that this condition is associated with a rare, de novo Pro814Leu variant in the major human Munc13 paralog UNC13A (also known as Munc13-1). Electrophysiological studies in murine neuronal cultures and functional analyses in Caenorhabditis elegans revealed that the UNC13A variant causes a distinct dominant gain of function that is characterized by increased fusion propensity of synaptic vesicles, which leads to increased initial synaptic vesicle release probability and abnormal short-term synaptic plasticity. Our study underscores the critical importance of fine-tuned presynaptic control in normal brain function. Further, it adds the neuronal Munc13 proteins and the synaptic vesicle priming process that they control to the known etiological mechanisms of psychiatric and neurological synaptopathies.

Original languageEnglish
Pages (from-to)1005-1018
Number of pages14
JournalJournal of Clinical Investigation
Volume127
Issue number3
DOIs
Publication statusPublished - 1 Mar 2017

Cite this

Lipstein, N., Verhoeven-Duif, N. M., Michelassi, F. E., Calloway, N., Van Hasselt, P. M., Pienkowska, K., ... Brose, N. (2017). Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder. Journal of Clinical Investigation, 127(3), 1005-1018. https://doi.org/10.1172/JCI90259
Lipstein, Noa ; Verhoeven-Duif, Nanda M. ; Michelassi, Francesco E. ; Calloway, Nathaniel ; Van Hasselt, Peter M. ; Pienkowska, Katarzyna ; Van Haaften, Gijs ; Van Haelst, Mieke M. ; Van Empelen, Ron ; Cuppen, Inge ; Van Teeseling, Heleen C. ; Evelein, Annemieke M.V. ; Vorstman, Jacob A. ; Thoms, Sven ; Jahn, Olaf ; Duran, Karen J. ; Monroe, Glen R. ; Ryan, Timothy A. ; Taschenberger, Holger ; Dittman, Jeremy S. ; Rhee, Jeong Seop ; Visser, Gepke ; Jans, Judith J. ; Brose, Nils. / Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder. In: Journal of Clinical Investigation. 2017 ; Vol. 127, No. 3. pp. 1005-1018.
@article{2d12cf70b9e94199bafddb9b375db0c6,
title = "Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder",
abstract = "Munc13 proteins are essential regulators of neurotransmitter release at nerve cell synapses. They mediate the priming step that renders synaptic vesicles fusion-competent, and their genetic elimination causes a complete block of synaptic transmission. Here we have described a patient displaying a disorder characterized by a dyskinetic movement disorder, developmental delay, and autism. Using whole-exome sequencing, we have shown that this condition is associated with a rare, de novo Pro814Leu variant in the major human Munc13 paralog UNC13A (also known as Munc13-1). Electrophysiological studies in murine neuronal cultures and functional analyses in Caenorhabditis elegans revealed that the UNC13A variant causes a distinct dominant gain of function that is characterized by increased fusion propensity of synaptic vesicles, which leads to increased initial synaptic vesicle release probability and abnormal short-term synaptic plasticity. Our study underscores the critical importance of fine-tuned presynaptic control in normal brain function. Further, it adds the neuronal Munc13 proteins and the synaptic vesicle priming process that they control to the known etiological mechanisms of psychiatric and neurological synaptopathies.",
author = "Noa Lipstein and Verhoeven-Duif, {Nanda M.} and Michelassi, {Francesco E.} and Nathaniel Calloway and {Van Hasselt}, {Peter M.} and Katarzyna Pienkowska and {Van Haaften}, Gijs and {Van Haelst}, {Mieke M.} and {Van Empelen}, Ron and Inge Cuppen and {Van Teeseling}, {Heleen C.} and Evelein, {Annemieke M.V.} and Vorstman, {Jacob A.} and Sven Thoms and Olaf Jahn and Duran, {Karen J.} and Monroe, {Glen R.} and Ryan, {Timothy A.} and Holger Taschenberger and Dittman, {Jeremy S.} and Rhee, {Jeong Seop} and Gepke Visser and Jans, {Judith J.} and Nils Brose",
year = "2017",
month = "3",
day = "1",
doi = "10.1172/JCI90259",
language = "English",
volume = "127",
pages = "1005--1018",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

Lipstein, N, Verhoeven-Duif, NM, Michelassi, FE, Calloway, N, Van Hasselt, PM, Pienkowska, K, Van Haaften, G, Van Haelst, MM, Van Empelen, R, Cuppen, I, Van Teeseling, HC, Evelein, AMV, Vorstman, JA, Thoms, S, Jahn, O, Duran, KJ, Monroe, GR, Ryan, TA, Taschenberger, H, Dittman, JS, Rhee, JS, Visser, G, Jans, JJ & Brose, N 2017, 'Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder' Journal of Clinical Investigation, vol. 127, no. 3, pp. 1005-1018. https://doi.org/10.1172/JCI90259

Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder. / Lipstein, Noa; Verhoeven-Duif, Nanda M.; Michelassi, Francesco E.; Calloway, Nathaniel; Van Hasselt, Peter M.; Pienkowska, Katarzyna; Van Haaften, Gijs; Van Haelst, Mieke M.; Van Empelen, Ron; Cuppen, Inge; Van Teeseling, Heleen C.; Evelein, Annemieke M.V.; Vorstman, Jacob A.; Thoms, Sven; Jahn, Olaf; Duran, Karen J.; Monroe, Glen R.; Ryan, Timothy A.; Taschenberger, Holger; Dittman, Jeremy S.; Rhee, Jeong Seop; Visser, Gepke; Jans, Judith J.; Brose, Nils.

In: Journal of Clinical Investigation, Vol. 127, No. 3, 01.03.2017, p. 1005-1018.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder

AU - Lipstein, Noa

AU - Verhoeven-Duif, Nanda M.

AU - Michelassi, Francesco E.

AU - Calloway, Nathaniel

AU - Van Hasselt, Peter M.

AU - Pienkowska, Katarzyna

AU - Van Haaften, Gijs

AU - Van Haelst, Mieke M.

AU - Van Empelen, Ron

AU - Cuppen, Inge

AU - Van Teeseling, Heleen C.

AU - Evelein, Annemieke M.V.

AU - Vorstman, Jacob A.

AU - Thoms, Sven

AU - Jahn, Olaf

AU - Duran, Karen J.

AU - Monroe, Glen R.

AU - Ryan, Timothy A.

AU - Taschenberger, Holger

AU - Dittman, Jeremy S.

AU - Rhee, Jeong Seop

AU - Visser, Gepke

AU - Jans, Judith J.

AU - Brose, Nils

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Munc13 proteins are essential regulators of neurotransmitter release at nerve cell synapses. They mediate the priming step that renders synaptic vesicles fusion-competent, and their genetic elimination causes a complete block of synaptic transmission. Here we have described a patient displaying a disorder characterized by a dyskinetic movement disorder, developmental delay, and autism. Using whole-exome sequencing, we have shown that this condition is associated with a rare, de novo Pro814Leu variant in the major human Munc13 paralog UNC13A (also known as Munc13-1). Electrophysiological studies in murine neuronal cultures and functional analyses in Caenorhabditis elegans revealed that the UNC13A variant causes a distinct dominant gain of function that is characterized by increased fusion propensity of synaptic vesicles, which leads to increased initial synaptic vesicle release probability and abnormal short-term synaptic plasticity. Our study underscores the critical importance of fine-tuned presynaptic control in normal brain function. Further, it adds the neuronal Munc13 proteins and the synaptic vesicle priming process that they control to the known etiological mechanisms of psychiatric and neurological synaptopathies.

AB - Munc13 proteins are essential regulators of neurotransmitter release at nerve cell synapses. They mediate the priming step that renders synaptic vesicles fusion-competent, and their genetic elimination causes a complete block of synaptic transmission. Here we have described a patient displaying a disorder characterized by a dyskinetic movement disorder, developmental delay, and autism. Using whole-exome sequencing, we have shown that this condition is associated with a rare, de novo Pro814Leu variant in the major human Munc13 paralog UNC13A (also known as Munc13-1). Electrophysiological studies in murine neuronal cultures and functional analyses in Caenorhabditis elegans revealed that the UNC13A variant causes a distinct dominant gain of function that is characterized by increased fusion propensity of synaptic vesicles, which leads to increased initial synaptic vesicle release probability and abnormal short-term synaptic plasticity. Our study underscores the critical importance of fine-tuned presynaptic control in normal brain function. Further, it adds the neuronal Munc13 proteins and the synaptic vesicle priming process that they control to the known etiological mechanisms of psychiatric and neurological synaptopathies.

UR - http://www.scopus.com/inward/record.url?scp=85015969576&partnerID=8YFLogxK

U2 - 10.1172/JCI90259

DO - 10.1172/JCI90259

M3 - Article

VL - 127

SP - 1005

EP - 1018

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -

Lipstein N, Verhoeven-Duif NM, Michelassi FE, Calloway N, Van Hasselt PM, Pienkowska K et al. Synaptic UNC13A protein variant causes increased neurotransmission and dyskinetic movement disorder. Journal of Clinical Investigation. 2017 Mar 1;127(3):1005-1018. https://doi.org/10.1172/JCI90259